Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satya Dash

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
International Journal of Obesity (2005)|September 23, 2018
Phenotypic and genetic analysis of an adult cohort with extreme obesityPriska Stahel, Shawn K Sud, So Jeong Lee, et al.
Primary Care Diabetes|May 13, 2018
Reprint of OASIS - Obesity Awareness and Insight ScalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Obesity Medicine|December 4, 2018
OASIS: The Obesity Awareness and Insight ScalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Eclinicalmedicine|October 22, 2020
22q11.2 microdeletion and increased risk for type 2 diabetesLily Van, Tracy Heung, Sarah L Malecki, et al.
Diabetes|May 18, 2023
Erratum. Association Between Obesity and Chronic Kidney Disease: Multivariable Mendelian Randomization Analysis and Observational Data From a Bariatric Surgery Cohort. Diabetes 2023;72:496-510Anthony Nguyen, Rana Khafagy, Yiding Gao, et al.
Diabetes|January 19, 2023
Association Between Obesity and Chronic Kidney Disease: Multivariable Mendelian Randomization Analysis and Observational Data From a Bariatric Surgery CohortAnthony Nguyen, Rana Khafagy, Yiding Gao, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2018
BASIS: The blood pressure awareness and insight scalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Endocrinology|December 17, 2021
Hypothalamic miR-1983 Targets Insulin Receptor β and the Insulin-mediated miR-1983 Increase Is Blocked by MetforminJennifer A Chalmers, Prasad S Dalvi, Neruja Loganathan, et al.
Brain and Behavior|July 10, 2025
Efficacy and Safety of Glucagon-Like Peptide-1 Agonists for Psychiatric Symptoms: A Systematic ReviewShakila Meshkat, Corinna Di Luciano, Alyssa Swiderski, et al.
Diabetes, Obesity & Metabolism|July 26, 2024
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors for the treatment of diabetes mellitus in liver transplant recipientsKatina Zheng, Amirhossein Azhie, Xiaoting You, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
International Journal of Obesity (2005)|September 23, 2018
Phenotypic and genetic analysis of an adult cohort with extreme obesityPriska Stahel, Shawn K Sud, So Jeong Lee, et al.
Primary Care Diabetes|May 13, 2018
Reprint of OASIS - Obesity Awareness and Insight ScalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Obesity Medicine|December 4, 2018
OASIS: The Obesity Awareness and Insight ScalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Eclinicalmedicine|October 22, 2020
22q11.2 microdeletion and increased risk for type 2 diabetesLily Van, Tracy Heung, Sarah L Malecki, et al.
Diabetes|May 18, 2023
Erratum. Association Between Obesity and Chronic Kidney Disease: Multivariable Mendelian Randomization Analysis and Observational Data From a Bariatric Surgery Cohort. Diabetes 2023;72:496-510Anthony Nguyen, Rana Khafagy, Yiding Gao, et al.
Diabetes|January 19, 2023
Association Between Obesity and Chronic Kidney Disease: Multivariable Mendelian Randomization Analysis and Observational Data From a Bariatric Surgery CohortAnthony Nguyen, Rana Khafagy, Yiding Gao, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 11, 2018
BASIS: The blood pressure awareness and insight scalePhilip Gerretsen, Julia Kim, Parita Shah, et al.
Endocrinology|December 17, 2021
Hypothalamic miR-1983 Targets Insulin Receptor β and the Insulin-mediated miR-1983 Increase Is Blocked by MetforminJennifer A Chalmers, Prasad S Dalvi, Neruja Loganathan, et al.
Brain and Behavior|July 10, 2025
Efficacy and Safety of Glucagon-Like Peptide-1 Agonists for Psychiatric Symptoms: A Systematic ReviewShakila Meshkat, Corinna Di Luciano, Alyssa Swiderski, et al.
Diabetes, Obesity & Metabolism|July 26, 2024
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors for the treatment of diabetes mellitus in liver transplant recipientsKatina Zheng, Amirhossein Azhie, Xiaoting You, et al.
Pageof 7